Thailand’s Chulalongkorn University is seeking approval from the Thai Food and Drug Administration (TFDA) to begin the first two phases of human trials of its mRNA COVID-19 vaccine. According to…
Read More
Thailand’s Chulalongkorn University is seeking approval from the Thai Food and Drug Administration (TFDA) to begin the first two phases of human trials of its mRNA COVID-19 vaccine. According to…
Read More
Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year, according…
Read More
The Thai cabinet approved a 3.6-billion-baht fund on Thursday for the development and production of Thailand’s first two vaccines to fight COVID-19, which are now entering their third phase of…
Read More
When Thailand began its battle against COVID-19 early last year, local scientists were quick to launch research programs on innovative weapons to contain the virus. So far, their hard work has…
Read More
Thailand’s Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development is recruiting 174 volunteers for human trials of its vaccine, known as ChulaCov19, scheduled to start at the end…
Read More
Human trials of the first Thai COVID-19 vaccine, developed by Chula Vaccine Research Centre (CVRC) at Chulalongkorn University and King Chulalongkorn Memorial Hospital, began today (Monday). Called “ChulaCov19”, it is…
Read MorePage 1 of 1